The active ingredients semaglutide and tirzepatide have been studied in large clinical trials of the FDA-approved products (e.g., STEP 1, SURMOUNT-1). Those trials studied the FDA-approved medications, not compounded formulations. Compounded medications, including formulations containing methylcobalamin, have not been evaluated by the FDA and were not studied in these trials. Individual results vary.
Important information about compounded medications
Compounded Semaglutide / Methylcobalamin and Compounded Tirzepatide / Methylcobalamin are prepared by a state-licensed 503A compounding pharmacy pursuant to a patient-specific prescription. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. They are not Ozempic®, Wegovy®, Mounjaro®, or Zepbound®, and are not generic equivalents of those products. Prescriptions are issued only when a licensed provider determines a compounded medication is clinically appropriate for you. Product images are for illustration only — your dispensed medication is prepared, labeled, and dispensed by the compounding pharmacy, whose name appears on your prescription label. Individual results vary.